These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 34328586)

  • 1. Quantum simulations of SARS-CoV-2 main protease M
    Wang Y; Murlidaran S; Pearlman DA
    J Comput Aided Mol Des; 2021 Sep; 35(9):963-971. PubMed ID: 34328586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19.
    Joshi T; Sharma P; Joshi T; Pundir H; Mathpal S; Chandra S
    Mol Divers; 2021 Aug; 25(3):1665-1677. PubMed ID: 32602074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin.
    Kwofie SK; Broni E; Asiedu SO; Kwarko GB; Dankwa B; Enninful KS; Tiburu EK; Wilson MD
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations.
    Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA
    Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.
    Yuce M; Cicek E; Inan T; Dag AB; Kurkcuoglu O; Sungur FA
    Proteins; 2021 Nov; 89(11):1425-1441. PubMed ID: 34169568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
    Amin SA; Banerjee S; Ghosh K; Gayen S; Jha T
    Bioorg Med Chem; 2021 Jan; 29():115860. PubMed ID: 33191083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M
    Rao P; Shukla A; Parmar P; Rawal RM; Patel B; Saraf M; Goswami D
    Biophys Chem; 2020 Sep; 264():106425. PubMed ID: 32663708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
    Jiménez-Alberto A; Ribas-Aparicio RM; Aparicio-Ozores G; Castelán-Vega JA
    Comput Biol Chem; 2020 Oct; 88():107325. PubMed ID: 32623357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro.
    Bharadwaj S; Dubey A; Yadava U; Mishra SK; Kang SG; Dwivedi VD
    Brief Bioinform; 2021 Mar; 22(2):1361-1377. PubMed ID: 33406222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV-2 Main Protease.
    Deeks HM; Walters RK; Barnoud J; Glowacki DR; Mulholland AJ
    J Chem Inf Model; 2020 Dec; 60(12):5803-5814. PubMed ID: 33174415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.
    Bhardwaj VK; Singh R; Das P; Purohit R
    Comput Biol Med; 2021 Jan; 128():104117. PubMed ID: 33217661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling SARS-CoV-2 Main Protease (M
    Gupta A; Zhou HX
    ACS Comb Sci; 2020 Dec; 22(12):826-832. PubMed ID: 33119257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2.
    Zhao Y; Zhu Y; Liu X; Jin Z; Duan Y; Zhang Q; Wu C; Feng L; Du X; Zhao J; Shao M; Zhang B; Yang X; Wu L; Ji X; Guddat LW; Yang K; Rao Z; Yang H
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117142119. PubMed ID: 35380892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.
    Nguyen HL; Thai NQ; Truong DT; Li MS
    J Phys Chem B; 2020 Dec; 124(50):11337-11348. PubMed ID: 33264025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational screening for potential drug candidates against the SARS-CoV-2 main protease.
    Silva Andrade B; Ghosh P; Barh D; Tiwari S; José Santana Silva R; Rodrigues de Assis Soares W; Silva Melo T; Santos Freitas A; González-Grande P; Sousa Palmeira L; Carlos Junior Alcantara L; Giovanetti M; Góes-Neto A; Ariston de Carvalho Azevedo V
    F1000Res; 2020; 9():. PubMed ID: 33447372
    [No Abstract]   [Full Text] [Related]  

  • 20. The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors.
    Silvestrini L; Belhaj N; Comez L; Gerelli Y; Lauria A; Libera V; Mariani P; Marzullo P; Ortore MG; Palumbo Piccionello A; Petrillo C; Savini L; Paciaroni A; Spinozzi F
    Sci Rep; 2021 Apr; 11(1):9283. PubMed ID: 33927258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.